LIDOLOG KIT Drug Recall Over Barcode Label Wrap Issue
Asclemed USA Inc. is recalling 18 Lidolog Kits because the label wrap covers the barcode, making it hard to scan. The recall affects products distributed within the U.S. in Tennessee.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a labeling problem where the label wrap covers the barcode, making it hard to scan, with no reported illness or injury.
Plain-English summary
Asclemed USA Inc. is recalling 18 Lidolog Kits. The product is a kit containing Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
The recall is due to a labeling issue: the label wrap covers the barcode, making it hard to scan. This is classified as a labeling problem under the FDA's Not Elsewhere Classified category.
The recalled product is identified by Lot: 070126X1, Exp. 12/31/2027. The distribution is within the U.S. - Tennessee.
Consumers or healthcare providers who have questions can contact Asclemed USA Inc. The FDA classification for this recall is Class III, which typically indicates a product that is unlikely to cause adverse health consequences.
The recalled product
- Product
- LIDOLOG KIT (LIDOCAINE, KENALOG, POVIDONE IODINE)
- Brand
- LIDOLOG KIT
- Manufacturer
- Asclemed USA Inc.
- Category
- Drug — Prescription Kit
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 070126X1
- Exp. 12/31/2027.
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · LIDOLOG KIT
- ModerateEugia lidocaine vial label wrap covers the barcode
FDA (Drugs) · 2026-06-10
Same category
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled Due to Subpotent Drug Concerns
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29